April 26, 2027
Hynes Convention CenterBoston, MA Viorel Simion, Ph.DDirector of Immunology at Sail BiomedicinesSpeaker
Profile
Viorel Simion, PhD, is Director of Immunology at Sail Biomedicines, where he leads cross-functional teams advancing in vivo CAR-T therapies toward IND and drives translational immunology strategy across multiple therapeutic platforms. He brings 15+ years of experience across biotech, pharma, and academia, with expertise in RNA therapeutics, biologics, T-cell engineering and translational biomarker development. His work focuses on engineering next-generation immune interventions for inflammatory and autoimmune disorders.
Agenda Sessions
In Vivo Transient Programming of T Cells with Targeted Nanoparticles Encapsulating eRNATM-encoded hCD19 CAR Achieves Deep Depletion of B cells in Blood and Lymphoid Tissues
, 3:00pmView Session